Therefore, our results indicated that membrane TLR9-Cav-1 is activated in the setting of bacterial sepsis, and that upregulation was correlated with improved clinical outcomes among patients with sepsis. The gene discussed is CAV1; the disease is bacterial infectious disease with sepsis.